Veeral Sheth, MD, MBA, FASRS, FACS

Clinical Assistant Professor

University of Illinois

Chicago, Illinois

Director of Clinical Research

University Retina and Macula Associates

Chicago, Illinois

Articles by Veeral Sheth, MD, MBA, FASRS, FACS

Treat and Extend Strategy for Anti-VEGF Injections

ByEhsan Rahimy, MD,Jonathan Jonisch, MD,Veeral Sheth, MD, MBA, FASRS, FACS,Ali Khan, MD, FACS, FASRS

June 29th 2023

Experts offer their clinical experience and advice for applying a treat and extend strategy with anti-vascular endothelial growth factor (Anti-VEGF) injections.

Real-World Long-Term Safety Data of Anti-VEGF Agents

ByEhsan Rahimy, MD,Jonathan Jonisch, MD,Veeral Sheth, MD, MBA, FASRS, FACS,Ali Khan, MD, FACS, FASRS

June 22nd 2023

Experts discuss safety data of anti-vascular endothelial growth factor (Anti-VEGF) agents while highlighting the importance of sharing this information with patients and relevant care providers.

Patient and Cross-Care Education Strategies for AMD and DME

ByEhsan Rahimy, MD,Jonathan Jonisch, MD,Veeral Sheth, MD, MBA, FASRS, FACS,Ali Khan, MD, FACS, FASRS

June 22nd 2023

Experts discuss strategies for educating patients, fellows, and shared-care providers on therapies and prospective outcomes for patients with age-related macular degeneration (AMD) or diabetic macular edema (DME).

Barriers to Optimal Treatment Outcomes

ByEhsan Rahimy, MD,Jonathan Jonisch, MD,Veeral Sheth, MD, MBA, FASRS, FACS,Ali Khan, MD, FACS, FASRS

June 15th 2023

Experts discuss barriers that prevent optimal outcomes for patients with age-related macular degeneration (AMD) or diabetic macular edema (DME).

Overview of Anti-VEGF Treatments for AMD and DME

ByEhsan Rahimy, MD,Jonathan Jonisch, MD,Veeral Sheth, MD, MBA, FASRS, FACS,Ali Khan, MD, FACS, FASRS

June 15th 2023

Experts provide an overview of anti-vascular endothelial growth factor (Anti-VEGF) treatment for patients with age-related macular degeneration (AMD) or diabetic macular edema (DME).